Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy
Clinical trial NCT00889954 · COMPLETED
Trial details
- NCT number
- NCT00889954
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.